Next Article in Journal
L-Arginine Supplementation and Metabolism in Asthma
Next Article in Special Issue
Pharmacological Evaluation of 3-Carbomethoxy Fentanyl in Mice
Previous Article in Journal
Comments on the Eslicarbazepine Acetate Section of the Article ‘Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications’
Open AccessArticle

Fentanyl and Spiradoline Interactions in a Place-Conditioning Black-White Shuttle-Box

1
Department of Pharmacology/Toxicology, Michigan State University, East Lansing, MI 48824, USA
2
Department of Environmental Quality, State of Michigan, Lansing, MI 48909, USA
3
Department of Biomedical Sciences, College of Osteopathic Medicine, University of New England, 11 Hills Beach Road, Biddeford, ME 04005, USA
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2011, 4(1), 101-116; https://doi.org/10.3390/ph401101
Received: 5 November 2010 / Revised: 20 December 2010 / Accepted: 22 December 2010 / Published: 24 December 2010
(This article belongs to the Special Issue Opioids)
Rats were trained for multiple sessions in a place-conditioning shuttle-box to explore motivational interactions of mu and kappa opioid agonists, specifically fentanyl reward and spiradoline aversion. In Phase 1, groups of rats received various doses of mu or kappa agonists, or placebo, testing for preference or aversion. Group A always received saline SC before 15-minute sessions. Group B received fentanyl SC (0.003, 0.006, 0.012 mg/kg), Group C received low and medium doses of agonists SC, and Group D received spiradoline (0.3, 0.6, 1.2 mg/kg) SC during Training Sessions 1-4, rats being restricted to the drug-associated compartment. Rats received saline when restricted to the placebo-associate compartment and on test days with access to both shuttle-box compartments. In Phase 2 of the study, Training Session 5, Combinations of mu and kappa agonists were substituted in Groups B, C, and D. Dose-related preference to fentanyl and aversion to spiradoline occurred during Test Sessions 1-4. During Test Session 5, fentanyl preference in Group B was suppressed by spiradoline, rats in Group C had a saline-like response to combined agonists, and spiradoline aversion in Group D was attenuated by fentanyl. These findings suggest that combined doses of mu and kappa agonists, while additive for antinociception, offset the rewarding and punishing effects of each other. View Full-Text
Keywords: fentanyl; spiradoline; place preference; place aversion; two-compartment; shuttle-box fentanyl; spiradoline; place preference; place aversion; two-compartment; shuttle-box
MDPI and ACS Style

Rech, R.H.; Briggs, S.L.; Mokler, D.J. Fentanyl and Spiradoline Interactions in a Place-Conditioning Black-White Shuttle-Box. Pharmaceuticals 2011, 4, 101-116.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop